Rat Model for Hyperprolactinemia (HPRL) Rattus norvegicus (Rat) Disease model

Hyperprolactinaemia

Add to Cart Distributors
Overview
Properties
  • Prototype SpeciesHuman
  • SourceInduced by dopamine receptor blocker of metoclopramide
  • Model Animal StrainsSD rats (SPF), Female, 8~10W, 200~250g
  • Modeling GroupingRandomly divided into six group: Control group, Model group, Positive drug group and Test drug group
  • Modeling Period2~4 weeks
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Rat Model for Hyperprolactinemia (HPRL) Packages (Simulation)
  • Rat Model for Hyperprolactinemia (HPRL) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Modeling Method

Rats were subcutaneously injected with the dopamine receptor blocker of metoclopramide 50 mg/kg a day,continuous 10d.

Model evaluation

Pathological results

Cytokines level

Statistical analysis

SPSS software is used for statistical analysis, measurement data to mean ± standard deviation (x ±ｓ), using t test and single factor analysis of variance for group comparison , P<0.05 indicates there was a significant difference, P<0.01 indicates there are very significant differences.

Recommend products